Teladoc (Germany) Performance

4LL Stock  EUR 4.05  0.03  0.75%   
The entity has a beta of 1.39, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Teladoc will likely underperform. At this point, Teladoc has a negative expected return of -0.71%. Please make sure to validate Teladoc's jensen alpha, treynor ratio, and the relationship between the standard deviation and total risk alpha , to decide if Teladoc performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Teladoc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
1
Teladoc Health Fading Hope - Seeking Alpha
11/14/2025
2
Carlos Nueno Sells 3,897 Shares of Teladoc Health Stock - MarketBeat
12/04/2025
3
Forget Teladoc and buy this healthcare stock instead - MSN
12/15/2025
4
Barclays Initiates Coverage on Teladoc with Equal Weight at 8.50 - Finviz
12/22/2025
5
BofA Securities lowers Teladoc stock price target to 7.50 on segment uncertainties - Investing.com Nigeria
01/05/2026
6
Is Teladoc Losing Its Edge As BetterHelp Shrinks And Rivals Crowd Into Virtual Care - simplywall.st
01/08/2026
7
Aug Swings How volatile is Teladoc Health Inc stock - Market Growth Report Expert Verified Movement Alerts - baoquankhu1.vn
01/12/2026
8
Teladoc stock holds steady as Stifel maintains rating amid service expansion - Investing.com
01/20/2026
9
Once Medicare Stops Covering Telehealth Services, Will Teladoc Health Stock be in Trouble - The Globe and Mail
01/28/2026
10
Jim Cramer on Teladoc I Dont See Any Reason to Own It - Finviz
02/04/2026
  

Teladoc Relative Risk vs. Return Landscape

If you would invest  644.00  in Teladoc on November 11, 2025 and sell it today you would lose (239.00) from holding Teladoc or give up 37.11% of portfolio value over 90 days. Teladoc is currently producing negative expected returns and takes up 3.4728% volatility of returns over 90 trading days. Put another way, 31% of traded stocks are less volatile than Teladoc, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Teladoc is expected to under-perform the market. In addition to that, the company is 4.3 times more volatile than its market benchmark. It trades about -0.2 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of volatility.

Teladoc Target Price Odds to finish over Current Price

The tendency of Teladoc Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 4.05 90 days 4.05 
close to 99
Based on a normal probability distribution, the odds of Teladoc to move above the current price in 90 days from now is close to 99 (This Teladoc probability density function shows the probability of Teladoc Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon the stock has the beta coefficient of 1.39 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Teladoc will likely underperform. Additionally Teladoc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Teladoc Price Density   
       Price  

Predictive Modules for Teladoc

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Teladoc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.584.067.54
Details
Intrinsic
Valuation
LowRealHigh
0.503.987.46
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.81-0.64-0.22
Details

Teladoc Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Teladoc is not an exception. The market had few large corrections towards the Teladoc's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Teladoc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Teladoc within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.97
β
Beta against Dow Jones1.39
σ
Overall volatility
0.76
Ir
Information ratio -0.27

Teladoc Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Teladoc for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Teladoc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Teladoc generated a negative expected return over the last 90 days
Teladoc has high historical volatility and very poor performance
Teladoc has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 2.57 B. Net Loss for the year was (1 B) with profit before overhead, payroll, taxes, and interest of 1.76 B.
About 72.0% of the company shares are owned by institutions such as pension funds
Latest headline from news.google.com: Jim Cramer on Teladoc I Dont See Any Reason to Own It - Finviz

Teladoc Fundamentals Growth

Teladoc Stock prices reflect investors' perceptions of the future prospects and financial health of Teladoc, and Teladoc fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Teladoc Stock performance.

About Teladoc Performance

By analyzing Teladoc's fundamental ratios, stakeholders can gain valuable insights into Teladoc's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Teladoc has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Teladoc has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 21.31  33.91 
Return On Tangible Assets(0.64)(0.67)
Return On Capital Employed(0.46)(0.48)
Return On Assets(0.33)(0.34)
Return On Equity(0.77)(0.81)

Things to note about Teladoc performance evaluation

Checking the ongoing alerts about Teladoc for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Teladoc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Teladoc generated a negative expected return over the last 90 days
Teladoc has high historical volatility and very poor performance
Teladoc has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 2.57 B. Net Loss for the year was (1 B) with profit before overhead, payroll, taxes, and interest of 1.76 B.
About 72.0% of the company shares are owned by institutions such as pension funds
Latest headline from news.google.com: Jim Cramer on Teladoc I Dont See Any Reason to Own It - Finviz
Evaluating Teladoc's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Teladoc's stock performance include:
  • Analyzing Teladoc's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Teladoc's stock is overvalued or undervalued compared to its peers.
  • Examining Teladoc's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Teladoc's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Teladoc's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Teladoc's stock. These opinions can provide insight into Teladoc's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Teladoc's stock performance is not an exact science, and many factors can impact Teladoc's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Teladoc Stock analysis

When running Teladoc's price analysis, check to measure Teladoc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teladoc is operating at the current time. Most of Teladoc's value examination focuses on studying past and present price action to predict the probability of Teladoc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teladoc's price. Additionally, you may evaluate how the addition of Teladoc to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data